Jen Sato leads HealthTech Build and is driving its expanded offerings to amplify collaboration and close the technology gap within healthcare. She believes that the innovation community is key to solving healthcare’s biggest challenges and founded HealthTech Build with Matt Gross to advance and support healthcare innovators. Jen brings exceptional corporate experience, with over a decade in leadership roles at BCG, BearingPoint and EY. As a strategic healthcare advisor and entrepreneur, Jen has a keen understanding of the frictions and opportunities within healthcare, how to build trust and community with stakeholders, and identify and drive commercial value.

Matt Gross formed the HealthTech Build nonprofit after his child was diagnosed with a rare disease and he encountered the technology challenges of the healthcare system. He has worked for 20+ years as a software developer and product and engineering leader. He is a technology advisor for startups, hospital systems, and healthcare companies. He currently leads HealthTech Build’s technology initiative for AI evaluation in healthcare.

As an MIT-trained scientist turned founder/CEO and startup executive, Christine Hsieh has a unique blend of expertise in technology, data, and strategic vision when it comes to building new ventures. Most recently she was the Chief Strategy and Research Officer at DayToDay Health, a digital care management company that was acquired by Babylon Health. Prior to DayToDay Health Christine launched her entrepreneurial career as Founder and CEO of Salubris Analytics. She is currently an Entrepreneur in Residence at MIT, Operating Partner at Third Culture Capital, and serves on the Board of Directors of HealthTech Build. Follow Christine on LinkedIn.

A.J. Tibbetts is a shareholder at Greenberg Traurig Boston and an intellectual property attorney specializing in computer- and electronics-implemented technologies, including networking, NLP, digital health, life sciences AI, and computational biology. Leveraging his prior experience as a software engineer, A.J. provides tailored IP advice covering open source policies, patents, trade secrets, licensing, and litigation. He has successfully invalidated bogus software patents and defended his clients’ patents from invalidation. Regularly recognized as one of the top IP attorneys in Massachusetts and a top-recommended IP attorney by Boston-area startups, A.J. serves on the board of a regional MedTech industry group and is an active speaker on protecting AI-driven technology.

Jarrod McLean has over 20 years of entrepreneurial leadership experience architecting and implementing enterprise level software solutions, internet applications, and native mobile iPhone and Android solutions. Expert in research, requirements, design, development, implementation, distribution, education of software solutions, and fast innovation techniques to speed the development lifecycle and product to market.

Thomas Busby is passionate about innovation and takes pride in enhancing value and facilitating significant positive impact for his clients. As a leader with a technology and life sciences investment banking firm, he brings transactional expertise and an innovative client-specific approach to private equity and merger and acquisition advisory services, with a focus on middle-market growth companies.

Dean Andrews believes in the power of technology to improve lives. As a leader in a software engineering services firm, he helps MedTech and Life Science companies achieve their business and product goals through strategic approaches, innovation, and creative problem solving. Dean brings his experience as a business consultant, startup advisor, product owner, engineering manager, and author to deliver value to all his clients and partners.

Michael K. Barron provides legal services to emerging technology and life science growth companies. He advises companies, entrepreneurs, and investors in the areas of formation and governance, early and later stage debt and equity financings, mergers and acquisitions, employment and executive compensation, and intellectual property matters.